Cyclobarbital
Cyclobarbital, also known as cyclobarbitol or cyclobarbitone, is a barbiturate derivative.[2] It was available in Russia as a fixed-dose combination with diazepam (100 mg cyclobarbital + 10 mg diazepam; brand name Reladorm) for the treatment of insomnia but was discontinued in 2019.
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral (tablets) |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Metabolism | Hepatic |
Excretion | Renal |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII |
|
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.127 |
Chemical and physical data | |
Formula | C12H16N2O3 |
Molar mass | 236.271 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
References
- Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
- Breimer DD, Winten MA (March 1976). "Pharmacokinetics and relative bioavailability of cyclobarbital calcium in man after oral administration". European Journal of Clinical Pharmacology. 09 (5–6): 443–50. doi:10.1007/bf00606563. PMID 989475. S2CID 20271169.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.